This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 May-Jun;142(3):62-3.

Review: short-acting insulin analogues reduce glycosylated hemoglobin more than regular human insulin but only in adults with type 1 diabetes

David M Kendall¹

Affiliations

PMID: 15862062

Comment

Review: short-acting insulin analogues reduce glycosylated hemoglobin more than regular human insulin but only in adults with type 1 diabetes

David M Kendall. ACP J Club. 2005 May-Jun.

. 2005 May-Jun;142(3):62-3.

Author

David M Kendall¹

Affiliation

¹ International Diabetes Center, Minneapolis, Minnesota, USA.

PMID: 15862062

No abstract available

PubMed Disclaimer

Comment on

Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.
Siebenhofer A, Plank J, Berghold A, Narath M, Gfrerer R, Pieber TR. Siebenhofer A, et al. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003287. doi: 10.1002/14651858.CD003287.pub3. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003287. doi: 10.1002/14651858.CD003287.pub4. PMID: 15495047 Updated.

Publication types

Actions